|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,803.30 INR | -0.29% |
|
+3.78% | -18.43% |
| 08/07 | Concord Biotech Limited, Q4 2025 Earnings Call, May 30, 2025 | |
| 02/07 | Stellon Biotech Inc announced that it has received $0.0015 million in funding from Concord Biotech Limited | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 219.87Cr | ||||||
| 7.67TCr | ||||||
| 6TCr | ||||||
| 5.47TCr | ||||||
| 3.8TCr | ||||||
| 1.97TCr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition